I N T R O D U C T I O N
GABA A receptors consist of a pseudosymmetrical, pentameric array of transmembrane subunits that form a receptor/Cl Ϫ ion channel complex. GABA changes from an excitatory to an inhibitory neurotransmitter within 2 wk of birth, due to reversal of the Cl Ϫ gradient (Obrietan and van den Pol 1995; Rivera et al. 1999) . GABA A receptor function is allosterically modulated by a variety of endogenous factors such as phosphorylation, pH, neurosteroids and Zn 2ϩ (Hevers and Lüddens 1998; Huang and Dillon 1999; Moss and Smart 1996) . In addition, a number of pharmacologic agents modulate the receptor, including benzodiazepines, barbiturates, general anesthetics, and convulsants (see Hevers and Lüddens 1998) . Based on a repertoire of Ն20 subunits (␣1-6, ␤1-3, ␥1-3, ␦, , ⑀, 1-3, , and ), the molecular architecture of native GABA A receptors is extremely heterogeneous (Bonnert et al. 1999; Hevers and Lüd-dens 1998) . Pharmacological studies of recombinant receptors have shown that individual subunits and their subtypes confer different sensitivities to GABA A receptor modulators (Hevers and Lüddens 1998) .
The hypothalamus plays an important role in regulation of a number of autonomic functions, including food intake, body temperature, cardiorespiratory activity, nociception/analgesia, circadian rhythms, and the endocrine system (for review, see Meister 1993) . GABA suppresses the activity of hypothalamic neurons and has been suggested to be the dominant inhibitory neurotransmitter in the hypothalamus (Decavel and van den Pol 1990) . GABA A receptors as measured by [
3 H]muscimol binding are found throughout the hypothalamus (Xia and Haddad 1992) . In situ hybridization studies of the hypothalamus have demonstrated that mRNA for ␣2, ␤3, ␥2, and ⑀ subunits is highly expressed, whereas mRNA for ␣1, ␣3, ␣5, ␤1, and ␥1 subunits is moderately expressed (Whiting et al. 1997; Wisden et al. 1992 ). In addition, message for ␤2 and ␥3 subunits is minimally expressed, whereas that for ␣4, ␣6, and ␦ subunits is negligible or absent (Wisden et al. 1992) . Immunocytochemical studies suggest the existence of ␣1, ␣2, ␤2, ␤3, and ␥2 subunits in hypothalamic magnocellular neurons (Fenelon and Herbison 1995) and ␣1, ␣2, ␣5, ␤2/␤3, and ␥2 in other hypothalamic regions (Davis et al. 2000; Fritschy and Mohler 1995; Pirker et al. 2000) . Although the aforementioned techniques are clearly informative, it is accepted that conclusions derived using them may be limited. For instance, mRNA levels do not necessarily correlate with expression of functional receptors (Saha et al. 2001) . Moreover, results from immunohistochemical studies may be impacted by tissue preparation and integrity, antibody selectivity, and the possible labeling of incompletely assembled and/or subcellular receptors. Thus the aim of the present study was to conduct a pharmacological analysis of a physiologically intact system to obtain functional evidence of expression of GABA A receptor subunits that are purported to exist in the hypothalamus.
M E T H O D S

Hypothalamic brain slices
Sprague Dawley rats (Indianapolis, IN), postnatal day (P) 1-14 (either sex) were rapidly decapitated. Chemical anesthesia was not used because of its well-known influence on GABA A receptors (Franks and Lieb 1994) . All procedures were conducted in accordance with the National Institutes of Health Guide for Care and Use of Laboratory Animals. All stages of brain dissection and tissue slicing were conducted in ice-cold (ϳ4°C) artificial cerebrospinal fluid (ACSF) of the following composition (in mM): 124 NaCl, 5.0 KCl, 1.3 MgSO 4 , 26 NaHCO 3 , 1.24 KH 2 PO 4 , 2.4 CaCl 2 , and 10 glucose; 300 mosM and pH ϳ7.4 after equilibration with a 95%-5% CO 2 gas mixture (carbogen). Thin hypothalamic slices (ϳ200 m) were cut with a vibratome (VSL, World Precision Instruments); slices were submerged in ACSF (22-25°C) aerated with the carbogen gas mixture. Slices were transferred to a recording chamber (ϳ2 ml) and superfused continuously (7-10 ml/min, 22-25°C) with saline. To minimize synaptic influences on neurons under investigation, experiments were conducted in a synaptic blockade medium consisting of the following (in mM): 128 NaCl, 3.0 KCl, 11.4 MgCl 2 , 10 HEPES, 2.0 CaCl 2 , and 10 glucose, 300 mosM and pH 7.3. This superfusion medium has been shown to block both evoked and spontaneous chemical synaptic potentials in medullary neurons (Dean et al. 1997) .
Individual hypothalamic neurons within the slice were visualized using an upright, fixed stage microscope (Nikon Optiphot-2UD) equipped with standard Hoffman modulation contrast (HMC) optics and a video camera system (Sony model XC-75 CCD video camera module, Tandy video monitor). Pipette tip location was acquired at low magnification (ϫ4) via the CCD camera. The anatomical location of each recorded neuron was determined by comparison to plates in a stereotaxic atlas (Paxinos and Watson 1986) .
Whole cell patch-clamp recording
Whole cell patch recordings were made at room temperature (22-25°C). Except during acquisition of current-voltage relationships, cells were voltage-clamped at Ϫ60 mV. Patch pipettes of borosilicate glass (M1B150F, World Precision Instruments) were pulled (Flaming/ Brown, P-87/PC, Sutter Instrument, Novato, CA) to a tip resistance of 7-8 M⍀. The pipette solution contained (in mM): 140 CsCl, 10 EGTA, 10 HEPES, and 4 Mg-ATP; pH 7.2. GABA was prepared in the extracellular solution and was applied (10 s in most cases) to cells via gravity flow using a Y-shaped tube positioned near the target cell. With this system, the 10 -90% rise time of the junction potential at the open tip was 60 -120 ms. GABA-induced Cl Ϫ currents from the whole cell configuration were obtained using a patch-clamp amplifier (PC-501A, Warner Instruments, Hamden, CT) equipped with a 5101-01G headstage. GABA-induced Cl Ϫ currents were low-pass filtered at 5 kHz, monitored on an oscilloscope and a chart recorder (Gould TA240), and stored on a computer (pClamp 6.0, Axon Instruments) for subsequent analysis. Sixty to 80% series resistance compensation was applied at the amplifier. To monitor the possibility that access resistance changed over time or during different experimental conditions, at the initiation of each recording, we measured and stored on our digital oscilloscope the current response to a 5-mV voltage pulse. This stored trace was continually referenced throughout the recording. If a change in access resistance was observed throughout the recording period, the patch was aborted and the data were not included in the analysis.
Data analysis
Concentration-response profiles were generated for GABA and a number of modulatory compounds. Agonist concentration-response profiles were fitted to the following equation:
, where I and I max represent the normalized GABA-induced current at a given concentration and the maximum current induced by a saturating concentration of agonist, respectively. EC 50 is the half-maximal effective agonist concentration, and n is the Hill coefficient. Ligand applications were separated by 3-min intervals to allow for recovery from desensitization when present.
Effects of antagonists were analyzed using the equation:
, where I is current at a given concentration of drug, IC 50 ϭ the concentration of drug yielding a current half of I max , and n is the Hill coefficient. All data are presented as means Ϯ SE. Student's t-test (paired or unpaired) was used to determine statistical significance (P Ͻ 0.05). Analysis of the effects of both agonists and antagonists was performed using the GABA EC 25 concentration (10 M); this concentration generates a stable current, elicits minimal receptor desensitization and allows for several-fold drug-induced potentiation of the GABA-evoked response. The effects of antagonists were expressed as inhibition of the steady-state GABA currents. Effects of agonists were quantified as the magnitude of potentiation of peak GABA current amplitude.
Drugs
GABA, (Ϫ)-bicuculline methiodide, picrotoxin, zolpidem, ZnCl 2 , furosemide, dehydroepiandrosterone sulfate (DHEAS), diazepam, methyl-6,7-dimethoxy-4-ethyl-␤-carboline (DMCM), and 5␣-pregnan-3␣-hydroxy-20-one (3␣-OH-DHP) were obtained from Sigma (St. Louis, MO). Loreclezole was a gift from Janssen Pharmaceutical (Natick, MA). Picrotoxin, 3␣-OH-DHP, lorecelezole, zolpidem, DMCM, DHEAS, and furosemide were initially prepared in a dimethyl sulfoxide (DMSO) stock solution. The final concentration of DMSO was Ͻ0.05% (vol/vol) when diluted to the desired concentration in saline.
R E S U L T S
In all hypothalamic neurons tested, application of GABA activated an inward current when the membrane potential was voltage clamped at Ϫ60 mV. The recorded currents were outwardly rectifying, reversed at the Cl Ϫ equilibrium potential, and completely blocked by the GABA A receptor antagonist bicuculline (Fig. 1, A and B ). These characteristics demonstrate that the evoked currents were due to activation of GABA A receptors.
GABA sensitivity
The sensitivity to GABA provides some information about receptor subunit composition. The concentration-dependent response of hypothalamic neurons to GABA (1-3,000 M) is illustrated in Fig. 1C . The maximal amplitude of GABA-gated currents, typically achieved at a concentration of 300 M, was 2,735 Ϯ 189 pA (n ϭ 27). EC 50 values ranged from 11.4 to 44 M (median ϭ 20 M, n ϭ 11) and Hill coefficient values ranged from 1.2 to 2.25 (median ϭ 1.6, n ϭ 11). The mean GABA EC 50 (20 Ϯ 1.6 M) and Hill coefficients (1.7 Ϯ 0.2) of the entire group were similar to the median values, suggesting a single population of cells.
Diazepam, zolpidem and Zn 2ϩ sensitivity
The benzodiazepine-site ligand diazepam is known to be dependent on the presence of the ␥ subunit and is influenced by the ␣ subunit present in the receptor (Knoflach et al. 1996; Mckernan et al. 1995) . We assessed diazepam's ability to potentiate hypothalamic GABA-activated current in the present investigation. Coapplication of diazepam (0.01-3 M) with 10 M GABA significantly enhanced GABA-gated current; threshold for the stimulatory effect was 30 nM, and maximal potentiation (to 206 Ϯ 12% of control) was achieved at a concentration of 3 M (Fig. 2, A and D) . The EC 50 and Hill coefficient for the diazepam effect was 60 Ϯ 17 nM and 1.57 Ϯ 0.56, respectively (n ϭ 3-7).
The affinity of zolpidem is also influenced by the ␣ subunit isoform present in GABA A receptors. Zolpidem has high affinity for GABA A receptors containing an ␣1 subunit and is nearly insensitive to GABA A receptors containing ␣5 subunits (Hevers and Lüddens 1998; . Zolpidem (0.01-10 M) markedly potentiated the current induced by 10 M GABA in all cells (n ϭ 14) recorded from the hypothalamus (Fig. 2B) . The average EC 50 was 0.19 Ϯ 0.07 M and 3 M zolpidem maximally potentiated the GABA current to 210 Ϯ 18% of the control GABA response (Fig. 2D) .
Inhibition of GABA A receptors by Zn 2ϩ is influenced by the receptor subunit composition, in particular the presence of the ␥ subunit (Gingrich and Burkat 1998; Smart et al. 1991) . As shown in Fig. 2C , GABA-activated currents in hypothalamic neurons were sensitive to varying concentrations of Zn 2ϩ (1-1,000 M). In the presence of 10 M GABA, 1 M Zn 2ϩ caused a slight but significant potentiation of steady-state currents in 5/5 cells tested (to 114 Ϯ 4.9% of control, P Ͻ 0.05). Concentrations of Zn 2ϩ beyond 1 M inhibited GABA-gated currents with an IC 50 of 70.5 Ϯ 17 M and a Hill coefficient value of 0.9 Ϯ 0.14 (n ϭ 5, Fig. 2D ). Currents were decreased to ϳ10% of control in the presence of 1 mM Zn 2ϩ . The responses to both diazepam and Zn 2ϩ indicate hypothalamic GABA A receptors express ␣, ␤, and ␥ subunits.
Loreclezole and DMCM sensitivity
Loreclezole is often used to distinguish ␤2-3-containing receptors from ␤1-containing receptors because it is more potent in the former receptors than the latter . As Fig. 3A shows, coapplication of loreclezole (0.3-100 M) with 10 M GABA enhanced the GABA current in all the cells tested (n ϭ 18) in a concentration-dependent manner. Loreclezole was insoluble at concentrations Ͼ30 M. However, the potentiating effect appeared nearly saturated at that concentration, so an EC 50 value could be estimated (mean EC 50 ϭ 4.4 Ϯ 0.7 M, range ϭ 1.8 -10.0 M). The maximal enhancement of peak current was 194 Ϯ 12% of control (range: 119 -272%) with 30 M loreclezole. At higher concentrations (Ͼ10 M), loreclezole produced an increase in the current decay rate (Fig. 3A) .
Positive modulation of GABA A receptors by the ␤-carboline DMCM is also dependent on the ␤ subunit isoform. Figure 3B shows that concentrations of DMCM at Ն10 M caused a modest potentiation of the GABA response. The maximal effect (to 141 Ϯ 12.8% of control) was observed at 30 M DMCM. The average EC 50 from 11 cells was 7.7 Ϯ 3.2 M.
3␣-OH-DHP and furosemide sensitivity
3␣-OH-DHP, an endogenous progesterone metabolite, has been shown to differentially modulate GABA A receptor function in a subunit-selective manner (Brussaard et al. 1997; Maitra and Reynolds 1999; Wohlfarth et al. 2002; Zhu et al. 1996) . As shown in Fig. 4A , 3␣-OH-DHP potentiated GABAactivated currents in a concentration-dependent manner. Because the effect of 3␣-OH-DHP could not be readily washed out, it was necessary to use a new slice for determination of effects of different concentrations of 3␣-OH-DHP. Thus full concentration-response profiles were not collected. In addition, because 3␣-OH-DHP can directly open GABA A receptor-Cl Ϫ channels at concentrations Ͼ1 M (Ueno et al. 1997), we did not evaluate concentrations Ͼ1 M in the present investigation. Nevertheless, it is apparent that hypothalamic GABA A receptors are markedly sensitive to 3␣-OH-DHP, as GABA currents increased to 187 Ϯ 20 and to 423 Ϯ 48% of the control in response to 0.3 M (n ϭ 7) or 1 M 3␣-OH-DHP (n ϭ 8), respectively (Fig. 4B) .
Furosemide is a loop diuretic that acts as a selective, noncompetitive antagonist of ␣4-or ␣6-containing GABA A receptors, with IC 50 values in the micromolar range (Knoflach et al. 1996; Korpi and Lüddens 1997) . In 26 hypothalamic neurons tested, 300 M furosemide, a concentration that inhibited the response to GABA by 39 Ϯ 2% of control in rat recombinant ␣6␤2␥2 receptors (n ϭ 7, data not shown), had no effect on GABA-activated current. Increasing the furosemide concentration Յ1 mM was also without effect in all hypothalamic neurons tested (n ϭ 4).
Picrotoxin and DHEAS sensitivity
The CNS convulsant picrotoxin exerts its effects via blockade of GABA A receptors. Although picrotoxin appears to be an effective blocker in most preparations (Bell-Horner et al. 2000; Krishek et al. 1996; Newland and Cull-Candy 1992) , subunitspecific differences in affinity of picrotoxin for GABA A receptor blockade do exist (Bell-Horner et al. 2000) . Examples of typical responses of a hypothalamic neuron to picrotoxininduced inhibition of the GABA response are illustrated in Fig.  5A . When coapplied with 10 M GABA, picrotoxin (0.1-30 M) induced a modest inhibition of peak GABA current and subsequently markedly enhanced the rate of current decay. The IC 50 value for picrotoxin inhibition of steady-state current was 2.6 Ϯ 0.4 M, and the Hill coefficient was 1.1 Ϯ 0.1 (Fig. 5C ).
DHEAS is a noncompetitive antagonist of GABA A receptors in a number of preparations (Majewka et al. 1990) . Figure 5B illustrates the DHEAS-mediated inhibition of the response to 10 M GABA in a hypothalamic neuron. DHEAS reversibly inhibited the current amplitude and accelerated current decay in a concentration-dependent fashion. Coapplication of 300 M DHEAS with 10 M GABA reduced the GABA steadystate current to 7.7 Ϯ 3.5% of control. The IC 50 and Hill Table 1 for mean values. coefficients were 16.7 Ϯ 2.3 M and 0.9 Ϯ 0.1, respectively, for DHEAS inhibition of GABA-activated current in hypothalamic neurons (n ϭ 6, Fig. 5C ).
The efficacies and potencies of the different ligands modulating GABA A receptors in hypothalamic neurons are summarized in Table 1 . Locations of all hypothalamic neurons (n ϭ 69) studied in this investigation are shown in Fig. 6 . All neurons tested were in the periventricular hypothalamus, and were located in the posterior, dorsomedial, lateral, ventomedial, and arcuate hypothalamic nuclei.
D I S C U S S I O N
The involvement of GABA in regulating activity of hypothalamic neurons is well documented (Decavel and van den Pol 1990; Shonis and Waldrop 1995) . Whereas several studies have assessed the potential expression of GABA A receptor subunits in the hypothalamus, a functional characterization of these receptors has not been conducted. Thus we have performed a pharmacologic and physiologic analysis of hypothalamic GABA A receptors. We chose to use the thin brain slice preparation in this analysis. This system more closely resembles the physiologic condition of the intact brain than isolated cultured cells and at the same time permits the rapid and consistent exposure of neurons to various exogenous ligands.
Analysis of ␣ subunit isoform
The response to GABA itself varies significantly between receptors, depending on which ␣ subunit is present. The sensitivity to GABA of ␣6-and ␣5-containing receptors (Hevers and Lüddens 1998; Knoflach et al. 1993 ) is 5-to 20-fold greater than those expressing ␣1, ␣2, or ␣3 subunits (BellHorner et al. 2000; Huang and Dillon 1998). The GABA EC 50 for these latter receptors is 15-30 M (Bell-Horner et al. 2000) , which is comparable to the value we obtained in hypothalamic neurons (20 M). The fact that the individual EC 50 values were relatively evenly distributed around the mean does not support the existence of subsets of GABA A receptors with widely disparate GABA affinities.
Effects of diazepam are also influenced by ␣ subunit isoform. The EC 50 of diazepam for stimulation of hypothalamic GABA-gated current was 60 nM in the present investigation. This is nearly identical (65 nM) to that reported by Amin et al. Table 1 for mean values.
(1997) for diazepam stimulation of recombinant ␣1␤2␥2 receptors. The efficacy of diazepam is significantly greater in ␣3-expressing compared with ␣1-expressing GABA A receptors. Ducic et al. (1993) reported a 350% potentiation by diazepam of the GABA response in ␣3␤1␥2 receptors, whereas ␣1␤1␥2 receptors were potentiated ϳ125%. In agreement with these previous studies, we also observed that the maximal response to diazepam was 311% of control in rat recombinant ␣3␤2␥2 GABA A receptors, which is approximately three times greater than that of rat ␣1␤2␥2 receptors (data not shown). In the present study, the average maximal stimulation of an EC 25 GABA response by diazepam was just over 100% (range ϭ 68 -155%). Thus significant expression of ␣3-containing receptors appears minimal. In addition, none of the neurons tested appeared to express as their predominant GABA A receptor those incorporating ␣4 or ␣6 subunits. This is based on responses to both diazepam and furosemide. All hypothalamic neurons responded to diazepam, and recombinant receptors expressing ␣4 or ␣6 subunits are insensitive to diazepam (Knoflach et al. 1996) . Sensitivity to diazepam does not of course eliminate the possibility that receptors expressing ␣4 or ␣6 subunits may also be present in hypothalamic neurons. However, all hypothalamic neurons were also insensitive FIG. 5. Inhibition of GABA-activated currents by picrotoxin (PTX) and dehydroepiandrosterone sulfate (DHEAS). A and B: representative traces recorded from individual neurons. Both antagonists inhibited peak current and accelerated current decay in a concentration-dependent manner. The duration of all drug application was 10 s. C: mean concentration-response profiles for inhibition of GABA current by picrotoxin or DHEAS. Each point is a mean response (n ϭ 5-6) normalized to the control GABA response. Mean effects of PTX and DHEAS are presented in Table 1 . Values represent percentage inhibition of GABA steady-state currents. Maximal response is expressed as a percentage of the control response to GABA (100%). Data are the means Ϯ SE for the indicated number (n) of cells studied. Multiple values for n indicate varying numbers of cells tested at different concentrations of those concentration-response profiles. The number in brackets indicates the concentration range tested. EC 50 or IC 50 values were calculated from the concentration-response relationships fitted in Figs. 1-6 as described in METHODS. ND, not determined. Values for antagonists (*) represent effect on steady-state GABA currents; values for agonists represent effect on peak GABA current amplitude. DMCM, methyl-6,7-dimethoxy-4-ethyl-␤-carboline; 3␣-OH-DHP, 5␣-pregnan-3␣-hydroxy-20-one; DHEAS, dehydroepiandrosterone sulfate. FIG. 6. Schematic representation of majority of recording sites studied in the experiment. Slices in A and D represent the rostral and caudal extremes, respectively, encompassing the hypothalamic region that was investigated. ARC, arcuate hypothalamic nucleus; DM, dorsomedial hypothalamic nucleus; DMD, dorsomedial hypothalamic nucleus, diffuse; LH, lateral hypothalamic area; PH, posterior hypothalamic area; VMH, ventromedial hypothalamic nucleus. The drawing sections were adapted from a stereotaxic atlas for adult rats (Paxinos and Watson 1986). to the diuretic furosemide. Furosemide blocks ␣4-and ␣6-expressing receptors with M affinity but is ineffective in other receptor configurations (Knoflach et al., 1996; Korpi and Lüd-dens 1997) . Thus the results together suggest few hypothalamic neurons utilize receptors incorporating ␣4 or ␣6 subunits as the predominant ␣ subunit isoform.
Zolpidem has essentially no effect in ␣5-containing receptors and displays high affinity for ␣1-and ␣2-containing receptors (Hadingham et al. 1993; Lüddens et al. 1995) . All neurons tested in the present investigation were stimulated by zolpidem, suggesting a lack of neurons that express predominantly ␣5-containg receptors. Taken together, results with GABA, diazepam, and zolpidem are consistent with the existence of functional hypothalamic GABA A receptors that express predominantly ␣1 and/or ␣2 isoforms of the ␣ subunit. Receptors incorporating ␣3, ␣4, ␣5, and ␣6 subunits, if present, represent minority populations. Our findings expand significantly on experiments that have used visualization techniques to evaluate subunit expression in the hypothalamus. Wisden et al. (1992) found minimal and undetectable levels of ␣4 and ␣6 mRNA, respectively. mRNA for all other ␣ subunits was present to varying degrees, with mRNA for the ␣2 isoform being most consistently and strongly evident. Immunohistochemical studies indicated the existence of both ␣1 and ␣2 subunits and a lack of expression of ␣4 or ␣6 subunits in the most parts of hypothalamus (Davis et al. 2000; Fritschy et al. 1994; Pirker et al. 2000) . Davis et al. (2000) has shown that the density of immunoreactivity for ␣1 and ␣2 subunits varies with specific hypothalamic nuclei and that the relative density of these subunits in some hypothalamic nuclei switches by P20. It should be noted that because our recordings were obtained only in animals up to P14 in age, conclusions regarding functional subunit expression must be restricted to this age range.
Analysis of ␤ subunit isoform
The potentiating action of loreclezole depends on the presence of either ␤2-or ␤3-containing GABA A receptors and is absent in ␤1-containing receptors (Hevers and Lüddens 1998; . In the present study, loreclezole potentiated GABA-activated currents in all hypothalamic neurons tested. Loreclezole at high concentrations can also directly gate the GABA A receptor, and this effect is also influenced by the ␤ subunit isoform (Sanna et al. 1996) . We have confirmed this direct activation effect of loreclezole in recombinant ␣1␤2␥2 receptors (unpublished observations). Thus in the present report the effect on GABA A receptors of high loreclezole likely comprise both modulatory and direct gating effects. However, the subunit-selective effects for both allosteric modulation and direct activation are the same (Sanna et al. 1996) . Thus our conclusions are unchanged.
Positive modulation of GABA A receptors by the ␤-carboline DMCM has been suggested to be due to interaction at the same site (Asn290) responsible for loreclezole stimulation of receptors expressing ␤2/␤3 subunits (Stevenson et al. 1995) . DMCM (Ն10 M) caused a modest potentiation of hypothalamic GABA A receptors, suggesting the functional expression of receptors incorporating ␤2 and/or ␤3 subunits. It should be noted that we cannot rule out the possible coexistence of ␤1 with ␤2/␤3 subunits in the same neuron because the sensitivity to loreclezole or DMCM does not necessarily mean the absence of ␤1 subtype. In general, the ␤2 subunit is recognized as the most ubiquitous in the CNS. With regard to expression of mRNA, the ␤3 isoforms appears to be the most highly expressed in the hypothalamus (Wisden et al. 1992) , whereas protein detection using immunocytochemical studies indicate the presence of ␤1-3 subunits (Pirker et al. 2000) . Our data provide functional confirmation that ␤2/␤3 subunit-containing GABA A receptors are widely expressed in the hypothalamic areas.
Analysis of ␥ ␦ and ⑀ subunits
In vivo, ␣ and ␤ subunits generally combine with either a ␥ or ␦ subunit (Hevers and Lüddens 1998). However, binary receptors of only ␣ and ␤ subunits can readily form functional GABA A receptors, and they are known to exist in specific brain regions (Brickley et al. 1999; Kawahara et al. 1993) . None of our experiments suggested the existence of binary ␣␤ receptors in hypothalamic neurons. Moreover, our pharmacological analyses favor expression of ␥ over ␦ subunits in hypothalamic GABA A receptors. For instance, the IC 50 for Zn 2ϩ is significantly greater in ␣␤␥ receptors (ϳ50 M) than in ␣␤ receptors (ϳ1 M) (Gingrich and Burkat 1998; Smart et al. 1991) . We obtained in hypothalamic neurons a value consistent with the former (70.5 M). In addition, neurons in the present investigation were sensitive to diazepam and zolpidem, which requires the presence of a ␥2 subunit in combination with an ␣ and a ␤ subunit (Pritchett et al. 1989 ). The maximal efficacy of diazepam to enhance an EC 20 [GABA] in ␣1␤1␥2 receptors was 86 -135% (similar to the maximal efficacy of 106% we recorded in hypothalamic neurons), whereas only approximately a 25-58% potentiation was observed in ␣2␤1␥1/3 receptors (Ducic et al. 1993; Wafford et al. 1993a ).
Responses to the neurosteroid 3␣-OH-DHP also favor expression of the ␥ subunit over expression of the ␦ subunit. In the present studies, we observed 323% potentiation of GABAactivated current in response to 1 M 3␣-OH-DHP. The maximal potentiation is similar to values reported for ␣1␤2␥2 receptors (Maitra and Reynolds 1998; Zhu et al. 1996) and is several-fold less than observed with ␣1␤2 receptors (Maitra and Reynolds 1998). Finally, the maximal efficacy we noted for 3␣-OH-DHP also suggests the ␦ subunit does not coexpress with the ␣, ␤, and ␥ subunits (thus forming an ␣␤␥␦ receptor), as the presence of ␦ along with these other subunits diminishes the efficacy of 3␣-OH-DHP several-fold below that which we observed in the present investigation (Zhu et al. 1996 ; but see Mihalek et al. 1999) . As with our investigation of which ␣ subunits may be functional in the hypothalamus, our data confirm and expand the in situ hybridization studies of Wisden et al. (1992) and immunohistochemical studies of Peng et al. (2002) . They found no evidence for the existence of the ␦ subunit, while mRNA for all ␥ subunits (although mainly ␥1 and ␥2) was present. Our functional studies revealed no evidence for ␦ subunit expression and are most consistent with the suggestion that the ␥ subunit expressed in the hypothalamus is likely the ␥2 isoform.
The ⑀ subunit has been reported to express in the arcuateventromedial region of the hypothalamus via immunohistochemistry and in situ hybridization (Whiting et al. 1997) . GABA A receptors expressing ␣, ␤, and ⑀ subunits have high sensitivity to GABA (average EC 50 of 4 M in ␣1␤1⑀ recep-tors) and are insensitive to stimulation by benzodiazepines (Kasparov et al. 2001; Whiting et al. 1997) . In the present report, no hypothalamic neurons had a GABA EC 50 Ͻ11 M, and all were responsive to stimulation by diazepam. Thus functional expression of neurons with the ␣␤⑀ configuration may be minimal.
In summary, results of pharmacological analysis of hypothalamic GABA A receptors have provided insight about likely subunit configurations expressed in these neurons. The predominant ␣ and ␤ isoforms are likely ␣1 and/or ␣2 and ␤2 and/or ␤3, respectively. Our data suggest these subunits generally coassemble with the ␥2 subunit. We further suggest that ␣3, ␣4, ␣5, ␣6, ␤1, and ␦ subunits express minimally in functional receptors. Given that the GABA A receptor Cl Ϫ channels participate in many hypothalamic functions, modulation of GABA A receptor function by both endogenous and exogenous modulators may have a profound influence on synaptic transmission in this region. In addition, the knowledge we obtained here should prove to be useful in predicting and explaining effects on various hypothalamic functions as newer therapeutics with greater subunit specificity continue to be developed.
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